Clinical trial

N-Acetyl Cysteine Supplementation in Therapy Refractory Major Depressive Disorders

NCT02972398

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2015-09-01

PhaseNA

Study timeline

Study start (actual)2015-09-01Date precision: month

Registry last updated2022-09-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Major Depressive Disordersunresolved

Interventions

N-acetylcysteineDRUG

placebo comparator of N-acetylcysteineDRUG

Sponsors & collaborators

Tianjin Anding Hospitallead sponsor

Mapped research locations

TianjinTianjin Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02972398 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.